Literature DB >> 11673533

The role of the individual domains in the structure and function of the catalytic region of a modular serine protease, C1r.

J Kardos1, P Gál, L Szilágyi, N M Thielens, K Szilágyi, Z Lõrincz, P Kulcsár, L Gráf, G J Arlaud, P Závodszky.   

Abstract

The first enzymatic event in the classical pathway of complement activation is autoactivation of the C1r subcomponent of the C1 complex. Activated C1r then cleaves and activates zymogen C1s. C1r is a multidomain serine protease consisting of N-terminal alpha region interacting with other subcomponents and C-terminal gammaB region mediating proteolytic activity. The gammaB region consists of two complement control protein modules (CCP1, CCP2) and a serine protease domain (SP). To clarify the role of the individual domains in the structural and functional properties of the gammaB region we produced the CCP1-CCP2-SP (gammaB), the CCP2-SP, and the SP fragments in recombinant form in Escherichia coli. We successfully renatured the inclusion body proteins. After renaturation all three fragments were obtained in activated form and showed esterolytic activity on synthetic substrates similar to each other. To study the self-activation process in detail zymogen mutant forms of the three fragments were constructed and expressed. Our major statement is that the ability of autoactivation and C1s cleavage is an inherent property of the SP domain. We observed that the CCP2 module significantly increases proteolytic activity of the SP domain on natural substrate, C1s. Therefore, we propose that CCP2 module provides accessory binding sites. Differential scanning calorimetric measurements demonstrated that CCP2 domain greatly stabilizes the structure of SP domain. Deletion of CCP1 domain from the CCP1-CCP2-SP fragment results in the loss of the dimeric structure. Our experiments also provided evidence that dimerization of C1r is not a prerequisite for autoactivation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11673533     DOI: 10.4049/jimmunol.167.9.5202

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Calcium-dependent conformational flexibility of a CUB domain controls activation of the complement serine protease C1r.

Authors:  Balázs Major; József Kardos; Katalin Adrienna Kékesi; Zsolt Lorincz; Péter Závodszky; Péter Gál
Journal:  J Biol Chem       Date:  2010-02-23       Impact factor: 5.157

2.  A molecular switch governs the interaction between the human complement protease C1s and its substrate, complement C4.

Authors:  Andrew J Perry; Lakshmi C Wijeyewickrema; Pascal G Wilmann; Menachem J Gunzburg; Laura D'Andrea; James A Irving; Siew Siew Pang; Renee C Duncan; Jacqueline A Wilce; James C Whisstock; Robert N Pike
Journal:  J Biol Chem       Date:  2013-04-16       Impact factor: 5.157

3.  Molecular determinants of the substrate specificity of the complement-initiating protease, C1r.

Authors:  Lakshmi C Wijeyewickrema; Tang Yongqing; Thuy P Tran; Phillip E Thompson; Jacqueline E Viljoen; Theresa H Coetzer; Renee C Duncan; Itamar Kass; Ashley M Buckle; Robert N Pike
Journal:  J Biol Chem       Date:  2013-04-15       Impact factor: 5.157

Review 4.  Disease-causing mutations in genes of the complement system.

Authors:  Søren E Degn; Jens C Jensenius; Steffen Thiel
Journal:  Am J Hum Genet       Date:  2011-06-10       Impact factor: 11.025

5.  A novel human complement-related protein, C1r-like protease (C1r-LP), specifically cleaves pro-C1s.

Authors:  Christina Ligoudistianou; Yuanyuan Xu; Gerard Garnier; Antonella Circolo; John E Volanakis
Journal:  Biochem J       Date:  2005-04-01       Impact factor: 3.857

6.  Complete sequencing and expression of three complement components, C1r, C4 and C1 inhibitor, of the classical activation pathway of the complement system in rainbow trout Oncorhynchus mykiss.

Authors:  Tiehui Wang; Christopher J Secombes
Journal:  Immunogenetics       Date:  2003-11-20       Impact factor: 2.846

7.  Structural determination of the complement inhibitory domain of Borrelia burgdorferi BBK32 provides insight into classical pathway complement evasion by Lyme disease spirochetes.

Authors:  Jialei Xie; Hui Zhi; Ryan J Garrigues; Andrew Keightley; Brandon L Garcia; Jon T Skare
Journal:  PLoS Pathog       Date:  2019-03-21       Impact factor: 6.823

8.  Design and Selection of Novel C1s Inhibitors by In Silico and In Vitro Approaches.

Authors:  Katalin Szilágyi; István Hajdú; Beáta Flachner; Zsolt Lőrincz; Júlia Balczer; Péter Gál; Péter Závodszky; Chiara Pirli; Balázs Balogh; István M Mándity; Sándor Cseh; György Dormán
Journal:  Molecules       Date:  2019-10-09       Impact factor: 4.411

9.  C1R Mutations Trigger Constitutive Complement 1 Activation in Periodontal Ehlers-Danlos Syndrome.

Authors:  Rebekka Gröbner; Ines Kapferer-Seebacher; Albert Amberger; Rita Redolfi; Fabien Dalonneau; Erik Björck; Di Milnes; Isabelle Bally; Veronique Rossi; Nicole Thielens; Heribert Stoiber; Christine Gaboriaud; Johannes Zschocke
Journal:  Front Immunol       Date:  2019-11-05       Impact factor: 7.561

Review 10.  Role of Neuropilin-1 in Diabetic Nephropathy.

Authors:  Tzvetanka Bondeva; Gunter Wolf
Journal:  J Clin Med       Date:  2015-06-17       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.